儲物症

Hoarding Disorder

儲物症的特徵是嚴重且持久地難以丟棄或離開物品，導致混亂、擁擠且妨礙正常生活空間的使用，2013年DSM-5（Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition）才將其放在強迫症及相關障礙症中。目前對於儲物症的臨床表徵、病因、共病現象及治療方式所知有限，國外研究顯示治療的藥物包括：paroxetine（為一種selective serotonin reuptake inhibitors, SSRIs）、venlafaxine（為一種serotonin-norepinephrine reuptake inhibitors, SNRIs）、methylphenidate，以及採認知和行為治療為基礎的介入，包括個別治療、團體治療或是讀書會支持小組等均對儲物症有療效，亦有可幫助儲物症家人的「家庭激勵者」（family-as-motivators, FAM）訓練。鑑於國內對於儲物症相關研究付之闕如，藉由探討相關文獻，以期對儲物症之流行病學、診斷、病因、共病現象，治療方式等有更全面性的認識與瞭解。

Hoarding disorder (HD) is characterized by severe and persistent difficulty on discarding or parting with possessions, leading to clutter and crowded that precludes normal use of living spaces. The 2013 DSM-5 (Diagnostic and Statistical Manual of Mental Disorders 5th edition) places it in obsessive compulsive disorder and related disorders. At present, there are limited knowledge about the clinical signs, etiology, comorbidity, and treatment of HD. The past articles have presented that some countries has used drugs, such as paroxetine (one kind of selective serotonin reuptake inhibitors, SSRIs), venlafaxine (one kind of serotonin-norepinephrine reuptake inhibitors, SNRIs), and methylphenidate. The cognitive behavioral therapy (CBT) based interventions, includes individual CBT, group CBT, and CBT-based bibliotherapy support groups help treat HD. The interventions of relatives, for example family-as-motivators training is also helpful for families of HD. In view of the lack of relevant research on HD in our country, we should know more about the epidemiology, diagnosis, etiology, comorbidity and treatment of HD by discussing relevant literature.